Insider · CIK 0001140119
Federica F. O'Brien
director
Files at MGNX (MACROGENICS INC), TELA (TELA Bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 28, 2025 | TELA TELA Bio, Inc. | AGrant or award Common Stock | +7,950 | $0.00 | $0 | 18,470 | May 30, 2025 |
| May 28, 2025 | TELA TELA Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +11,700 | $0.00 | $0 | 11,700 | May 30, 2025 |
| May 20, 2025 | MGNX MACROGENICS INC | MOption exercise Common Stock | +6,500 | - | - | 11,000 | May 22, 2025 |
| May 20, 2025 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -6,500 | $0.00 | $0 | 0 | May 22, 2025 |
| May 21, 2025 | MGNX MACROGENICS INC | AGrant or award Restricted Stock Unitderivative | +3,750 | $0.00 | $0 | 3,750 | May 22, 2025 |
| May 21, 2025 | MGNX MACROGENICS INC | AGrant or award Stock Option (right to buy)derivative | +22,000 | $0.00 | $0 | 22,000 | May 22, 2025 |
| May 21, 2025 | MGNX MACROGENICS INC | AGrant or award Stock Option (right to buy)derivative | +64,961 | $1.27 | $83k | 86,961 | May 22, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.